Keith Bragman
Director/Board Member presso Faculty of Pharmaceutical Medicine
Profilo
Keith Bragman is a trustee at the Faculty of Pharmaceutical Medicine.
He previously worked as a Director & Head-Global Development at UCB SA, Director at Innate Pharma SA, Non-Executive Director at ClinPhone Plc, Director at Unibioscreen SA, Vice President at Quintiles Transnational Corp., Head-Clinical Virology at Hoffmann-La Roche, Inc., and Head-Clinical Oncology at Bristol-Myers Squibb International Corp.
Posizioni attive di Keith Bragman
Società | Posizione | Inizio |
---|---|---|
Faculty of Pharmaceutical Medicine | Director/Board Member | 04/03/2010 |
Precedenti posizioni note di Keith Bragman
Società | Posizione | Fine |
---|---|---|
Unibioscreen SA
Unibioscreen SA Pharmaceuticals: MajorHealth Technology Unibioscreen is a privately held specialist oncology discovery & development company. Founded in 1999 and based in Brussels, Belgium. Unibioscreen has successfully discovered, patented and developed 2 novel, first-in-class anti-cancer drug candidates (chemotherapeutics) now in clinical phase I in cancer patients and has also a discovery pipeline. | Director/Board Member | 10/05/2011 |
ClinPhone Plc
ClinPhone Plc Packaged SoftwareTechnology Services The Group's principal activity is the provision of technology solutions to the clinical trials industry. The Group's technology, services and products provide its customers, typically pharmaceutical and biotechnology companies, collects data and arrange clinical trials. These includes a range of consultancy, services and software. The Group's products includes ClinPhone Patient Recruitment, ClinPhone Randomisation, ClinPhone Trial Supply Management, ClinPhone ePRO, ClinPhone Clinical Trials Management Software, ClinPhone Drug Accountability, ClinPhone Integration Services and ClinPhone Trial Supply Simulation. | Director/Board Member | 12/08/2009 |
Bristol-Myers Squibb International Corp. | Corporate Officer/Principal | - |
Hoffmann-La Roche, Inc.
Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Corporate Officer/Principal | - |
Quintiles Transnational Corp.
Quintiles Transnational Corp. Miscellaneous Commercial ServicesCommercial Services Quintiles Transnational Corp. provides biopharmaceutical development and commercial outsourcing services. It offers product development and integrated healthcare services, including commercial and observational solutions. The company was founded by Dennis B. Gillings and Gary Koch in September 1990 and is headquartered in Durham, NC. | Corporate Officer/Principal | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 2 |
---|---|
UCB | Health Technology |
INNATE PHARMA | Health Technology |
Aziende private | 6 |
---|---|
Quintiles Transnational Corp.
Quintiles Transnational Corp. Miscellaneous Commercial ServicesCommercial Services Quintiles Transnational Corp. provides biopharmaceutical development and commercial outsourcing services. It offers product development and integrated healthcare services, including commercial and observational solutions. The company was founded by Dennis B. Gillings and Gary Koch in September 1990 and is headquartered in Durham, NC. | Commercial Services |
Hoffmann-La Roche, Inc.
Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Health Technology |
ClinPhone Plc
ClinPhone Plc Packaged SoftwareTechnology Services The Group's principal activity is the provision of technology solutions to the clinical trials industry. The Group's technology, services and products provide its customers, typically pharmaceutical and biotechnology companies, collects data and arrange clinical trials. These includes a range of consultancy, services and software. The Group's products includes ClinPhone Patient Recruitment, ClinPhone Randomisation, ClinPhone Trial Supply Management, ClinPhone ePRO, ClinPhone Clinical Trials Management Software, ClinPhone Drug Accountability, ClinPhone Integration Services and ClinPhone Trial Supply Simulation. | Technology Services |
Faculty of Pharmaceutical Medicine | |
Unibioscreen SA
Unibioscreen SA Pharmaceuticals: MajorHealth Technology Unibioscreen is a privately held specialist oncology discovery & development company. Founded in 1999 and based in Brussels, Belgium. Unibioscreen has successfully discovered, patented and developed 2 novel, first-in-class anti-cancer drug candidates (chemotherapeutics) now in clinical phase I in cancer patients and has also a discovery pipeline. | Health Technology |
Bristol-Myers Squibb International Corp. |
- Borsa valori
- Insiders
- Keith Bragman